Panagora Asset Management’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
NTCM
CCM
SCM
RCMC
BCM
RIM
Panagora Asset Management's IRMD Position: Q1 2024 in Review
Panagora Asset Management sold out of iRadimed (IRMD) in Q1 2024, closing a stake of 25,683 shares — an estimated $1.22M sold.
Panagora Asset Management first reported a position in IRMD in Q3 2014 and held it in 18 quarters. The position peaked at $1.83M in Q1 2023. 126 funds tracked by Wall St. Rank hold IRMD as of Q1 2024.
- Panagora Asset Management reported no remaining iRadimed position as of Q1 2024 after selling out during the quarter.
- Panagora Asset Management sold 25,683 iRadimed shares in Q1 2024, an estimated $1.22M.
- Panagora Asset Management first reported a position in iRadimed in Q3 2014 and held it in 18 quarters.
- Panagora Asset Management's iRadimed position peaked at $1.83M in Q1 2023.
- 126 funds tracked by Wall St. Rank held iRadimed as of Q1 2024.
Based on Panagora Asset Management's 13F filing for Q1 2024, filed 7 May 2024.